Hyde Engineering + Consulting Inc, a global partner for solution-based pharmaceutical design and consultant services, has named Kalpesh Patel as its new chief operating officer, it was reported on Wednesday.
In the new role, Patel is to head the company's growing global enterprise, focusing on the growth strategies set by the company's board of directors and CEO, in order to increase profitability.
Kalpesh Patel joined the company in 2005 as an Engineer I, and then held roles of increasing responsibility at the company. Before joining Hyde he served as validation engineer with International Medication Systems Ltd.
Santhera Pharmaceuticals signs Gulf region distribution agreement with Uniphar
Novo Nordisk expands legal action over compounded 'semaglutide'
Neuraxpharm launches Neuraxpharm Australia
OncoZenge selects Meribel Pharma as CDMO for Phase 3 BupiZenge project
Fridays nominated for World Out of Home awards for weight loss campaign
Physiomics expands into biometrics with two contract wins and new division head
DELFI Diagnostics CTO receives 2025 Most Influential Women in Bay Area Business recognition
Healthcare Holding Schweiz AG acquires Effectum CH-Rep AG to expand services
iOncologi acquires TargImmune Therapeutics
Zydus enters exclusive talks to acquire majority stake in Amplitude Surgical
Adcendo's ADCE-T02 Phase I study IND application receives US FDA approval
WHO grants Actinogen Medical's Xanamem/UE2343 non-proprietary name 'emestedastat'